Search

Author/Creator Tran, David D

1. A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Issue 1 (15th November 2021)

Authors:
Butt, Omar H; Zhou, Alice Y; Huang, Jiayi; Leidig, William A; Silberstein, Alice E; Chheda, Milan G; Johanns, Tanner M; Ansstas, George; Liu, Jingxia; Talcott, Grayson; Nakiwala, Ruth; Shimony, Joshua S; Kim, Albert H; Leuthardt, Eric C; Tran, David D; Campian, Jian L
Journal:
Neuro-oncology advances
Issue:
Volume 3:Issue 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Issue 1 (29th April 2022)

Authors:
Butt, Omar H; Zhou, Alice Y; Huang, Jiayi; Leidig, William A; Silberstein, Alice E; Chheda, Milan G; Johanns, Tanner M; Ansstas, George; Liu, Jingxia; Talcott, Grayson; Nakiwala, Ruth; Shimony, Joshua S; Kim, Albert H; Leuthardt, Eric C; Tran, David D; Campian, Jian L
Journal:
Neuro-oncology advances
Issue:
Volume 4:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. EPCT-07. Updated report on the pilot study of using MRI-guided laser heat ablation to induce disruption of the peritumoral blood brain barrier to enhance deliver and efficacy of treatment of pediatric brain tumors. (3rd June 2022)

Authors:
Shatara, Margaret; Gauvain, Karen; Cantor, Evan; Meyer, Ashley; Ogle, Andrea; McHugh, Michele; Beck, Mary; Green, Tammy; King, Allison; Cluster, Andrew; Brossier, Nicole; Shimony, Joshua S; Abdelbaki, Mohamed S; Tran, David D; Campian, Jian; Leuthardt, Eric C; Rubin, Joshua; Limbrick, David
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 1
Page Start:
i37
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply. Issue 2 (December 2017)

Authors:
Weller, Michael; Butowski, Nicholas; Tran, David D; Recht, Lawrence D; Lim, Michael; Hirte, Hal; Ashby, Lynn; Mechtler, Laszlo; Goldlust, Samuel A; Iwamoto, Fabio; Drappatz, Jan; O'Rourke, Donald M; Wong, Mark; Hamilton, Mark G; Finocchiaro, Gaetano; Perry, James; Wick, Wolfgang; Green, Jennifer;...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 2(2017:Feb.)
Page Start:
e709
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Issue 10 (October 2017)

Authors:
Weller, Michael; Butowski, Nicholas; Tran, David D; Recht, Lawrence D; Lim, Michael; Hirte, Hal; Ashby, Lynn; Mechtler, Laszlo; Goldlust, Samuel A; Iwamoto, Fabio; Drappatz, Jan; O'Rourke, Donald M; Wong, Mark; Hamilton, Mark G; Finocchiaro, Gaetano; Perry, James; Wick, Wolfgang; Green, Jennifer;...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 10(2017:Oct.)
Page Start:
1373
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗